Nhep Universal

Letroz 2.5mg Tablet helps treat breast cancer in post-menopausal women. It may be used alone or with other treatments, such as surgery or radiation. It can also be used in patients with advanced breast cancer to stop the tumor from spreading to other parts of the body.

Femaford 2.5mg Letrozole Tablet is primarily used to treat hormone receptor-positive breast cancer in postmenopausal women. It works by lowering estrogen levels in the body, which helps slow or reverse the growth of certain types of breast tumors that rely on estrogen. It is also commonly prescribed for ovulation induction in women with fertility issues, such as those with polycystic ovary syndrome (PCOS). The tablet is usually taken once daily with or without food, as directed by a physician. Regular monitoring is essential during treatment to assess response and manage potential side effects like hot flashes, fatigue, or bone thinning.

Letrozole is used to treat certain types of breast cancer in women who have already stopped menstruating (postmenopausal). It is also used for women who have already had other cancer treatments (eg, tamoxifen). Female hormones that occur naturally in the body can increase the growth of some breast cancers.